Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Anemia 7Colorectal Neoplasms 4Anemia, Iron-Deficiency 4Postoperative Complications 3Neoplasms 3Adenocarcinoma 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Plexosarcoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Liver Neoplasms 1Inflammatory Breast Neoplasms 1Gastrointestinal Stromal Tumors 1Endometrial Neoplasms 1Colonic Neoplasms 1Carcinoma, Ductal, Breast 1Cancer Anaemia 1Aortic Aneurysm 1Advanced Gastric Carcinoma 1

Interventions

Paclitaxel 11Carboplatin 8Radiotherapy 6Cyclophosphamide 6Trastuzumab 5Chemotherapy, Adjuvant 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4Epirubicin 3Doxorubicin 3Cryosurgery 3Cisplatin 3pertuzumab 2Surgical Procedures, Operative 2Radiotherapy, Conformal 2Radiation 2Letrozole 2Lapatinib 2Cryotherapy 2Brachytherapy 2talimogene laherparepvec 1sargramostim 1ferric carboxymaltose 1atezolizumab 1aldesleukin 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Zoledronic Acid 1Vorinostat 1VPS Coriolus versicolor extract 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Ductal, Breast × ferric carboxymaltose × Clear all
NCT02125344 2017-07-13

A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)

GBG Forschungs GmbH

Phase 3 Completed
961 enrolled
Breast

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡